Research
Research
2016
Factors affecting Type 2 Diabetes management amongst out-patient
diabetic women aged 50 years and above at Kenyatta National
Hospital, Kenya
2016
DECLARATION
This thesis is my original work and has not been presented for a degree or a diploma in
any other University.
Signature ………………………………………..Date ……………………….................
Esta Mwaloma
This thesis has been submitted for examination with our approval as University
supervisors:
Signature …………………………………….....Date ……………………......................
Professor Joseph Gikunju
JKUAT, Kenya
Signature………………………………………...Date ………………………………….
Dr Joseph Mutai
KEMRI, Kenya
ii
DEDICATION
I dedicate this thesis to my wonderful family. I appreciate their support, understanding
and patience through the many years of study.
iii
ACKNOWLEDGEMENT
I would like to thank all of those people who helped make this thesis possible.
First, I wish to thank my advisors, Professor Joseph Gikunju and Dr. Joseph Mutai for
their tireless guidance, encouragement, support and patience.
I am grateful to all the participants who voluntarily opened their hearts and minds to
me during the data collection. I also wish to thank the staff at Kenyatta National
Hospital and especially the Diabetic clinic for their cooperation.
iv
TABLE OF CONTENTS
DECLARATION .........................................................................................................i
ACKNOWLEDGEMENT ........................................................................................iv
ABSTRACT..............................................................................................................xiv
INTRODUCTION ......................................................................................................1
RESULTS .................................................................................................................. 18
REFERENCES .........................................................................................................48
APPENDICES ...........................................................................................................54
vii
LIST OF TABLES
viii
LIST OF FIGURES
Figure 4.1: Benefits of smoking cessation..................................................... 43
Figure 4.2: Knowledge of the normal fasting range for blood glucose .........44
Figure 4.3: Frequency of visits to the KNH clinic ........................................46
ix
LIST OF APPENDICES
x
ABBREVIATIONS AND ACRONYMS
UN United Nations
xii
DEFINITION OF TERMS
Blood glucose - This is the amount of glucose (sugar) present in the blood of a
human. Normally, in mammals the body maintains the fasting
blood glucose level at a reference range between about 3.9 and
5.6 mM (mmol/L). .
BMI - This is a measure of body fat that is the ratio of the weight of
the body in kilograms to the square of its height in meters.
Diabetes management - This is dealing with short term events such as high or low
blood sugar to controlling it over the long term by
understanding the condition.
Glucose - This is sugar that can be linked to form carbohydrates and that
serves as a primary source of energy in the body.
Glycaemic Control - This is a medical term referring to the typical levels of blood
sugar (glucose) in a person with diabetes mellitus.
xiii
ABSTRACT
Diabetes Mellitus has emerged as one of the most challenging public health problems
currently. It affects over 366 million people worldwide and this figure is likely to
double by 2030. The greatest burden of this condition is felt in low and middle-income
countries which account for about 80% of all cases of diabetes. Diabetes prevalence
increases sharply with age, and it is projected that by the year 2025, the majority of
persons with diabetes will be aged 65years or older with 55% of diabetes deaths
occurring in women. The limited availability of high quality data on health
disaggregated by sex and age has been a major obstacle to gender responsive planning
and policy-making therefore it is urgent to collect, analyze and publish data
disaggregated by sex and age. The study therefore aimed to address the gap in
knowledge by focusing on the factors that affected diabetic women over 50 years of
age which included awareness levels, self management practices and socio economic
factors. The study adopted a cross sectional, descriptive study design. Structured
questionnaires were used to collect data. 105 women were selected for the study. Most
of the patients were in the 65 - 69 age group (22%) with 82.7% of the respondents
having moderate awareness levels, 16.3%. 54.87% of the respondents had a moderate
score of self-management practices, 38.5% had a high score of self-management
practices and 6.7% had a low score of self-management practices. It was concluded
from the study that decisions to seek care were influenced by a number of factors
which included signs and symptoms, support from the community, availability of
resources to seek care and services available at the health care facilities. Majority of
the respondents had moderate awareness about diabetic management however this
awareness has not led to any changes in the disease management because patients are
not sufficiently equipped with knowledge to comprehensively manage their disease.
This study recommends that the hospital management should offer diabetes education
at no cost to the patients and provide additional training of the health care providers
working in the diabetes clinic with skills for delivering adequate health education
message tailored to knowledge needs of Type 2 diabetic patients.
xiv
CHAPTER ONE
INTRODUCTION
1.1 Background Information
Diabetes Mellitus is a chronic condition that arises when the pancreas does not produce
enough insulin, or when the body cannot effectively use the insulin produced. Insulin is
a hormone made by the pancreas that helps „sugar‟ (glucose) to leave the blood and enter
the cells of the body to be used as „fuel‟. When a person has diabetes, either their
pancreas does not produce the insulin they need (Type 1 diabetes) or their body cannot
make effective use of the insulin they produce (Type 2 diabetes) (Alberti K. et al., 1998)
Diabetes Mellitus has emerged as one of the most challenging public health problems in
the 21st century. It currently affects over 366 million people worldwide and this figure is
likely to double by 2030. The greatest burden of this condition is felt in low and middle-
income countries, and these nations account for about 80% of all cases of diabetes. The
African continent counts approximately 13.6 million people with diabetes. The Africa
Region of the International Diabetes Federation (IDF), which mainly includes sub-
Saharan Africa, counts approximately 7 million people with diabetes. Estimates for the
region for 2025 are likely to double and reach 15 million. In Kenya for instance the
World Health Organization (WHO) estimates that the prevalence of diabetes in Kenya is
at 3.3% and predicts a rise to 4.5% by 2025 (WHO 2011).
Africa is often referred to as the youngest continent in terms of age structure. This may
contribute to the current relatively low prioritization of ageing issues in national policies
(Naidoo et al., 2010). Yet the annual growth rate of older persons in Africa has been
estimated at 3.1% between 2007 and 2015, and 3.3% between 2015 and 2050, greater
than the global average. In this context, it is concerning that there will be approximately
64.5 million Africans aged ≥55 years in 2015, and more than 103 million and 205
1
million in 2030 and 2050, respectively (Guariguata et al., 2011). Indeed it has been
predicted that the diabetes peak in Africa is expected to be in the oldest individual by
2035 (Guariguata et al., 2013).
The population of sub-Saharan Africa is set to grow from around 860 million in 2010 to
more than 1.3 billion by 2030. For age groups above 40 years, the increases will double
the size of the population. People aged 45-59 years are 8.5 times more likely to develop
diabetes than those aged 15-29 years; and those above the age of 60 are 12.5 times more
likely to develop diabetes. Based on the present prevalence rates in sub-Saharan Africa,
the demographic changes alone will account for an increase of 9.5 million people with
diabetes between 2010 and 2030 (DLF, 2010). In 2013, the majority of individuals with
diabetes in Africa were reported to be under 60 years of age with the highest proportion
(43.2%) in people aged 40–59 years (Guariguata et al. 2013).
In many settings, ageing women do not have the same access to health care as men or
younger women. The barriers to primary health care faced by older people are often
worse for older women. These barriers include lack of transportation, low literacy levels
and a lack of money to pay for services and medications. Because women live longer
than men and are more likely to be alone in old age, policymakers and practitioners must
pay special attention to the gender implications of long term care policies and
programmes (WHO, 2007).
Information is a vital tool enabling the pursuit of gender equity in all areas including in
health. The limited availability of high quality data on health disaggregated by sex and
age has been a major obstacle to gender responsive planning and policy-making.
Without knowing whether and in what dimensions of health, and in which population
subgroups disadvantages exist, there is no way to begin redressing gender or other
inequities in health. The urgency of collection, analysis and publication of data
disaggregated by sex and age cannot be overemphasized (WHO, 2010).
Most research carried out in Kenya has focused on those affected by diabetes as a whole
regardless of their gender or age. The objective of this study therefore was to address
this gap by focusing specifically on women over 50 years of age with an aim of
generating findings that can be utilized to resolve some of the challenges they face in
their diabetes management. The age of 50 years is thought to incorporate the
chronological, functional and social definitions of "old" in Africa and has been adapted
by the World Health Organization (WHO) for its minimum data set project. This age
cut-off has also been used in other studies in Africa (WHO, 2006).
3
attention. Diabetes affects women in uniquely gendered ways, many of which are related
to the underlying determinants of health and socioeconomic status.
The Kenyan constitution acknowledges that all age groups have the right of equal access
to health services. However significant health disparities continue to exist in diabetes.
Stopping the diabetes epidemic involves halting health disparities caused by age, sex and
socioeconomic factors. This study therefore aimed to address the gaps in knowledge by
focusing on the factors that affect outpatient Type 2 diabetic women over 50 years of
age attending Kenyatta National Hospital in the management of diabetes. The findings
will assist in generating policies that will ensure that there is prioritized allocation of
resources.
1.3 Justification
This study, carried out at Kenyatta National Hospital, aimed at providing findings that
will assist in diabetes management. Assessment of the women‟s awareness levels and
self management practices about diabetes is important in developing educational
material relevant to their age and sex. Assessing the socioeconomic and cultural factors
that affect their management is also important as strategies can be localized for
particular groups in terms of age and sex. Programs can be formulated specifically for
older women thereby reducing morbidity associated with diabetes and therefore improve
their quality of life. The findings will also assist in priority setting for
management of diabetes in older women by the Ministry of Health, Health insurers and
relevant Non Governmental Organizations.
4
2. What are the self diabetic management practices amongst Type 2 diabetic
women over 50 years?
3. What are socioeconomic factors that affect diabetes management amongst
Type 2 diabetic women over 50 years?
1.5 Objectives
5
CHAPTER TWO
LITERATURE REVIEW
2.1 Diabetes Mellitus
Diabetes is a chronic disease that occurs either when the pancreas does not produce
enough insulin or when the body cannot effectively use the insulin it produces. Insulin is
a hormone that regulates blood sugar. There are three main types of diabetes; Type 1
diabetes, Type 2 diabetes and gestational diabetes. Type 1 diabetes once known as
juvenile diabetes or insulin-dependent diabetes is a chronic condition in which the
pancreas produces little or no insulin; Gestational diabetes is a type of diabetes that
affects women during pregnancy. It is defined as any degree of glucose intolerance with
onset or first recognition during pregnancy. The definition applies whether insulin or
only diet modification is used for treatment and whether the condition persists after
pregnancy. It does not exclude the possibility that unrecognized glucose intolerance may
have antedated or begun concomitantly with the pregnancy (WHO, 2006).
Type 2 diabetes mellitus (T2DM) is the most common type of diabetes. The body is able
to produce insulin but either this is not sufficient or the body is unable to respond to its
effects (also known as insulin resistance), leading to a build-up of glucose in the blood.
Many people with T2DM remain unaware of their illness for a long time because
symptoms may take years to appear or be recognized, during which time the body is
being damaged by excess blood glucose. They are often diagnosed only when
complications of diabetes have already developed (Malecki, 2004).
Although the reasons for developing T2DM are still not known, there are several
important risk factors. These include; obesity, poor diet, physical inactivity, advancing
age, family history of diabetes and ethnicity The
6
majority of those with T2DM usually do not require daily doses of insulin to survive.
Many people are able to manage their condition through a healthy diet and increased
physical activity or oral medication. However, if they are unable to regulate their blood
glucose levels, they may be prescribed insulin. The number of people with T2DM is
growing rapidly worldwide. This rise is associated with economic development, ageing
populations, increasing urbanization, dietary changes, reduced physical activity, and
changes in other lifestyle patterns (Hu et al., 2001).
Regionally before the 1990s, diabetes was considered a rare medical condition.
Epidemiological studies carried out in that decade, however, provided evidence of a
trend toward increased incidence and prevalence of type 2 diabetes in African
populations (Sobngwi et al., 2001). Indeed, Africa is experiencing the most rapid
demographic and epidemiological transition in world history (Mosley et al., 1993). It is
characterized by a tremendous rise in the burden of non-communicable diseases
underlined by the increasing life expectancy and lifestyle changes resulting from the
reduction in infectious diseases and increased fertility, as well as Westernization
The prevalence of diabetes in Africa was approximately 3 million in 1994; but the
region is due to experience a two-to threefold increase by the year 2010 (Amos et
l.,1997). The highest prevalence is found in populations of Indian origin, followed by
black populations and Caucasians. Among the population of Indian origin in South
Africa and Tanzania, the prevalence is between 12 and 13 percent (Ramaiya et a1.,
7
1991). The prevalence in blacks follows a Westernization gradient, with that of rural
Africa generally below 1 percent but that of urban Africa between 1 and 6 percent. In
general the prevalence of type 2 diabetes is low in both rural and urban communities of
West Africa except in urban Ghana, where a high rate of 6.3 percent was recently
reported (Amoah, et a1., 2002). Moderate rates have been reported from South Africa:
4.8 percent in a semi-urban community in the Orange Free State, 6.0 percent in an urban
community of the Orange Free State, 5.5 percent in Durban (mostly occupied by the
Zulu tribe), and 8 percent in Cape Town (mostly occupied by the Xhosa tribe). Also,
moderate rates have been reported in studies from Tanzania.
Locally the International Diabetes Federation (IDF) estimated the prevalence of diabetes
to be about 3.3% in 2013. However, local studies have shown a prevalence of 4.2% in
the general population with a prevalence rate of 2.2% in the rural areas and as high as
12.2% in urban areas. Sadly, the majority of the people with diabetes are within the
productive age range of 45–64 years. These are the same individuals who are expected
to drive the economic engines of their countries in order to achieve the agreed
international development goals (Maina et al., 2011). In Kenya, Type 2 Diabetes
Mellitus is the more prevalent, and Kenyans are developing it younger than those in
developed countries. The age of onset of T2DM in Kenya is between 45 and 55,
compared with 64 years in developed countries. Kenyans are also at higher risk for
crippling or life-threatening complications, because they report to health centers when
the disease is advanced (Mwangi et al., 2011).
As in other parts of the World, in African countries, there are more elderly females than
males (UNSD, 2010). Indeed with increasing life expectancy, it should be expected that
there would be even more elderly females surviving.
Hence, elderly females will bear the bigger share of constraints caused by lack of
appropriate policies and plans aimed at improving the welfare of the population (Velkoff
and Kowal, 2007).
8
2.3 Risk factors for type 2 diabetes
There are controllable risk factors associated with diabetes, including obesity and an
inactive lifestyle. However, other uncontrollable risk factors, such as ethnicity and
genetics, also play a dramatic role.
Age and ethnicity are the two main non-modifiable risk factors of diabetes in Africa.
Glucose intolerance in Sub-Saharan Africa, as in other regions of the world, increases
with age in both men and women however, published studies lack uniformity on the age
range in which the prevalence of diabetes is observed. According to King et a1.,(1998),
in most developed communities the peak of occurrence falls in the age group of 65 years
or older, whereas in developing countries it is in the age group 45 to 64, and in Sub-
Saharan Africa it is in the age groups 20 to 44 and 45 to 64 years. Yet data from 12 other
studies from Sub-Saharan Africa indicate two peak age ranges of 45 to 64 and older than
65 years
factor for diabetes, but this was not the case in the Cape Town study (Levitt et al., 1993),
in which family history was not an independent risk factor.
Measure of Adiposity
Several studies from Sub-Saharan Africa have confirmed the association between the
prevalence of diabetes and a surrogate of obesity, body mass index (BMI). Reports from
Mali (Fisch et al., 1987), Nigeria (Cooper et al., 1997) and Tanzania (McLarty et al.,
1989) have shown that the prevalence of diabetes increases with increasing BMI. BMI
and obesity seem to be independent risk factors for diabetes (Levitt et al., 1993).
9
Physical Activity
There seems to be a significant relationship between physical inactivity and diabetes and
obesity (Sobngwi et al., 2002). Physical activity is more common in rural than urban
regions of Africa because rural populations rely on walking for transport and often have
intense agricultural activities as their main occupation. In Sub-Saharan Africa, walking
time and pace is drastically reduced in an urban community as compared with a rural
community. The main difference in physical activity between the two types of
community, however, is the use of walking in rural areas as a means of transportation.
The reduction in physical activity associated with life in a city partly explains the excess
prevalence of obesity in urban areas. In a South African study, the prevalence of a
sedentary lifestyle in Cape Town in subjects age 30 years and over was 39 percent for
men and 44 percent for women (Omar et al., 1993). Low physical activity was normal
for 22 percent of men and 52 percent of women in urban Tanzania, whereas it was usual
for only 10 percent of men and 15 percent of women living in rural areas (Edwards et
al., 2000). Cross-sectional data from 1,417 women age 15 to 83 years in a rural
community and an urban community in Cameroon showed that in all age groups, fasting
blood glucose levels were inversely associated with energy expenditure from walking
(Sobngwi, et a1.,2003). Rural dwellers' higher level of physical activity and related
energy expenditure compared with urban subjects goes far to explain why obesity was
found to be at least four times higher in urban areas than rural (Aspray et al., 2000).
Thus, lack of physical activity appears to be a significant risk factor for diabetes in Sub-
Saharan Africa
10
The following tests are used for the basic diagnosis: fasting plasma glucose (FPG) test
measures blood glucose in a person who has not eaten anything for at least 8 hours. This
test is used to detect diabetes and prediabetes. An oral glucose tolerance test (OGTT)
measures blood glucose after a person fasts at least 8 hours and 2 hours after the person
drinks a glucose-containing beverage. This test can be used to diagnose diabetes and
prediabetes. The FPG test is the preferred test for diagnosing diabetes because of its
convenience and low cost. However, it may miss some diabetes or prediabetes that can
be found with the OGTT. The FPG test is most reliable when done in the morning.
Research has shown that the OGTT is more sensitive than the FPG test for diagnosing
prediabetes, but it is less convenient to administer (WHO,1999).
The most serious microvascular diabetes complications are the eye complications.
Diabetic patients are strongly advised to have an annual ophthalmic exam. Diabetic
retinopathy is the leading cause of blindness in the working population of the Western
world. The risk of developing diabetic retinopathy or other microvascular complications
11
26 of diabetes depends on both the duration and the severity of hyperglycaemia (Almdal
et al., 2004).
Diabetes increases the risk that an individual will develop cardiovascular disease.
Although the precise mechanisms through which diabetes increases the likelihood of
atherosclerotic plaque formation are not completely defined, the association between the
two is profound (Laing et al., 2003). Cardiovascular disease is a major complication and
the leading cause of premature death among diabetic patients (Merz et a.,l 2002).
Diabetic patients have a 2 to 6 times higher risk for developing complications such as
ischemic heart disease, cerebrovascular disease and peripheral vascular disease than the
general population.
With bacterial and fungal infections diabetics have increased risk of cystitis and, more
important, of serious upper urinary tract infection as well as ear, nose, and throat
infections, necrotizing otitis externa principally occurs. Skin and soft tissue infections
are common in DM and may spread to adjacent bone causing osteomyelitis infection (
Eron et al., 2003). Diabetic patients are also in greater risk of infections than healthy
individuals. The association
between diabetes and increased susceptibility to infection in general is not supported by
strong evidence. However, many specific infections are more
common in diabetic patients and some occur almost exclusively in them. Other
infections occur with increased severity and are associated with an increased risk of
complications. Several aspects of immunity are altered in patients with diabetes. There is
evidence that improving glycaemic control improves immune function. Fungal cystitis,
rhino-cerebral mucormycosis and community-acquired pneumonia are among the most
common infections the diabetic patients suffer from (Gu et al., 1998)
Peripheral vascular disease, are often seen in patients who have foot infections. Poorly
controlled DM lead to impaired circulation and slow healing from small cuts. The
12
untreated damage, or failing to heal or unnoticed minor trauma may result in an infection
especially in the lower- extremity, where the blood flow delays, and micro-angiopathic
lesions lead to cellulitis, osteomyelitis, or nonclostridial gangrene that end in
amputation. In 2004 about 60% of non-traumatic lower limb amputations occur in
people with diabetes in USA. The complications of diabetes are far less common and
less severe in people who have well-controlled blood sugar levels (IDF, 2008)
Depending on the parameter, blood sugar level, blood pressure and weight should be
checked on a regular basis (Hoy B, 2007). Doctor-patient relationship, such as trust and
communication (Zgibor and Songer, 2001). Socio-economic status and its constituent
elements are accepted as being determinants of health. For primary prevention of
diabetes complications to be effective, patients must have access to quality medical care,
the means to pay for services (either through insurance or self-pay), and the knowledge
and skills to manage their diabetes on a day-to-day basis. Because access and self-care
are critical contributors to outcomes in patients with diabetes, socioeconomic mediators
(education and/or income) may play a significant role in these processes (Connolly et
al., 2001)
Therefore, Kenya, as well as other countries in the world, must redouble their efforts to
ensure follow-up of patients, whenever treatment has commenced and thus help reduce
and/or prevent the high death toll from this chronic and debilitating disease. The
adoption of a healthy diet and lifestyle requires not only individual behavioral changes,
but also changes in our food, built, and social environments. Public health strategies that
target the obesogenic environment are critical. Translating clinical and epidemiologic
findings into practice requires fundamental shifts in public policies and
health systems. To curb the diabetes epidemic, primary prevention through the
promotion of a healthy diet and lifestyle should be a global public policy priority (Zhang
et al., 2010).
14
CHAPTER THREE
15
(ii) Women who were unable to speak due to illness or frailty.
3.6 Sample size determination
The minimum sample size was calculated using the following formula (Araoye, 2004)
N = Z2Pq /D2
Where:
16
the women. Informed consent was sort from the respondents before administration of the
questionnaire.
17
CHAPTER FOUR
RESULTS
18
Table 4.1: Demographic data
19
9- 12 years 11 10.5
> 12 years 40 38.1
20
Table 4.2: Awareness levels of respondents on diabetes cause, cure and
management
Awareness levels on Diabetes Frequency Percent
Yes 64 61.0%
53 50.5%
Can diabetes be cured No
Yes 37 35.2%
Yes 14 13.3%
Figure 4.1 illustrates that majority of the respondents (97%) reported that it was
important and beneficial to one‟s health if one stopped smoking or taking alcohol.
21
Figure 4.1: Benefits of smoking cessation
The respondents were asked to indicate their perceptions about fasting range for blood
glucose. Figure 4.2 revealed that 59% of the respondents indicated between 4.4 – 6.1
mmol.
Figure 4.2: Knowledge of the normal fasting range for blood glucose
The study further sought to establish the level of awareness of the respondents about the
effect of fruit juice, exercise and other diseases on blood glucose. Table 4.3 indicates
22
that 93.3% of the respondents reported that fruit juice raised the level of blood glucose,
97.1% of the respondents said exercise lowered the level of blood glucose while 55.2%
indicated that other diseases could cause an increase in blood glucose.
Table 4.3: Effect of fruit juice, exercise and other diseases on blood glucose
23
Twenty five point seven percent (25.7%) of the respondents visited the clinic
after every three months, while 2.9 % visited once year (Figure 4.3).
The respondents were asked to indicate if they had been informed by the doctor about
named conditions that they could get from having diabetes. Table 4.4 indicates that
majority of the respondents were not aware of the consequences of having diabetes.
Blindness No 97 92.4%
24
Yes 8 7.6%
70 66.7
Glucose Meter No
Yes 35 33.3
13 12.4
Place of Testing Dispensary
Provincial Hospital 1 1
25
National Referral 17 16.2
Pharmacy 7 6.7
Others 2 1.9
23 21.9
Frequency of Checking Blood Glucose Clinic Appointments
Every month 42 40
Other 9 8.6
49 46.7
Diabetes Control Inject insulin
Exercise 1 1
Majority of respondents (90.5%) checked for red sores on their feet every day. All the
respondents checked their weights at clinic appointments. 37.1% of the respondents
checked their eyes on a yearly basis with 22.9% checking every six month. Majority
(91.4%) had an idea of dealing with emergencies indicating that they ate some form of
sugar (Table 4.6).
26
Table 4.6: Distribution of responses on self management practices of respondent
Self management practices
Frequency Percent
5.7
1.9
Checking feet for sores I don‟t check 6
Once a month 2 90.5
Everyday 95
Others 2 1.9
Majority (88.6 %) of the respondents indicated that they exercised on a daily basis with
84.8% exercising at home. Only 13.3% indicated that they did not exercise because of
some medical condition (Table 4.7).
27
Table 4.7 Distribution of responses on self management practices of respondent
Self management
practices Frequency Percent
I don't exercise 9 8.6
Frequency of exercise
Three times a week 2 1.9
Daily 93 88.6
Other 1 1
Home 89 84.8
Place of exercise
Other 16 15.2
Lack of time 2 1.9
Lack of money 2 1.9
Fear of exercise 1 1
Reasons for not exercising
I exercise 85 81
Medical condition 14 13.3
Of those respondents who used insulin, 39% indicated that they stored insulin in a pot of
cold water and 23.8% kept in the refrigerators. 55% of the respondents had never lacked
prescribed treatment in the hospitals for the last three months with 62% of those who
missed opting for other alternatives such as buying their own medication (Table 4.8).
28
Table 4.8 Distribution of responses on self management practices
Storage of insulin
37 35.2
25 23.8
55 52.4
Lack of prescribed treatment No 50 47.6
Yes
66
39 62.9
Alternative treatment Buying
Others 37.1
29
were accompanied by one person when they attended the clinic. 90.5% of the
respondents did not have a paid caretaker because they lived with family members.
93.3% stated that they did not believe herbalists or witchdoctors could cure their
condition while 2.9% were not sure (Table 4.9).
Frequenc Percen
Social Factors y t
0 ( none) 51 48.6%
30
How many people accompany you to KNH
1 person 51 48.6%
2 people 3 2.9%
No 77 73.3%
Does someone from your family take care of
you because of your ill health without being
paid for it
Yes 28 26.7%
Total 105 100%
31
Table 4.10: Distribution of responses on economic factors of respondent
Frequenc Percen
Economic Factors y t
How much do you pay for a blood glucose
Kshs 0-99 1 1%
test
100- 199 26 24.8%
>200 4 74.3%
32
0 - 999 99 94.3%
1000- 1999 1 1%
2000 -2999 4 3.8%
>3000 1 1%
How do you pay for the diabetic treatment
and care Current income 32 30.5%
Family support 72 68.6%
From saved 1 1%
money
Table 4.11: Analysis of education level, occupation and duration with diabetes
against awareness levels of diabetic management
Std.
N Mean
Mean awareness Deviation f and p value
33
Noformal
16 0.5938 0.19094
Education level education
Primary 62 0.6230 0.20805
Secondary 17 0.5221 0.16078
f=1.915;pvalue
College 9 0.4583 0.23385 =0.114
0 – 2 years
13 0.7212 0. 19199
3-5 years
19 0.5921 0.24239
Duration with
6-8 years
22 0.5341 0.18168
Diabetes
9-11 years
11 0.6023 0.17216
12 years and f=1.965;pvalue
40 0.5656 0.19355
above =0.106
34
variables and self management practices. This was supported by an f statistic of 1.868
(p=0.122) and 1.217 (p=0.308) respectively. However ANOVA results indicated that
there was significant relationship between places of residence, occupation with self
management practices. This was supported by an f statistic of 2.811 (p=0.043) and 5.264
(p=0.001) respectively. Table 4.12
35
Table 4.12: Analysis of demographics against self management practices
Std.
N Mean
Deviation f and p value
Education
16 1.7857 0.38244
level None
Primary 62 1.6993 0.35565
Secondary 17 1.8151 0.38800
College 9 2.0317 0.32363
University 1 1.9286 f=1.868;pvalue=0.1
22
48 1.8318 0. 36347
Residence Capital city
Other city 1 2.5000
Town 17 1.6681 0.31231 f=2.811;pvalue=0.0
43
36
Pensioner 13 2.064 0.31250 f=5.264;pvalue=0.0
01
Duration with
diabetes 0 – 2 years 13 1.6813 0. 52051
3 – 5 years 19 1.6654 0.38099
6 -8 years 22 1.7695 0.27614
9 – 11 years 11 1.6818 0.34011
12 years and f=1.217;pvalue=0.3
40 1.8518 0.35305
above 08
37
Table 4.13: Analysis of social economic and cultural factors on diabetes
management
Std.
N Mean
Deviation f and p value
Use of herbal
98 1.7675 0. 37647
medicine No
Don‟t know 4 1.5714 0.26726
f=0.597;pvalue=
Yes 3 1.8333 0.8248 0.553
Cost of testing 0 – 99
blood glucose in
Kshs 1 1.7143 0. 37647
Cost of insulin in
21 1.6837 0. 37647
Kshs 0 - 499
500 - 999 36 1.7480 0.26726
f=0.848;pvalue=
48 1.8065 0.8248
>1000 0.431
Distance to nearest
facility <1 km 69 1.7723 0. 37647
Between1&5k
13 1.7857 0.26726
m
f=0.219;pvalue=
23 1.7174 0.8248
>5 km 0.804
38
Residence
occupied when
attending KNH Nairobi 86 1.7650 0. 35788
ANOVA results indicated that there was a significant relationship between means of
transport used, transport costs and hospital expenses with management practices. This Iis
supported by an f statistic of 4.582 (p=0.012), 3.128 (p=0.029) and 4.360 (p=0.006)
respectively. Table 4.14
Transport costs in
Kshs 0 - 199 6 1.3690 0.17738
200 - 499 55 1.8052 0.33261
500 - 799 27 1.7116 0.39397
39
>800 17 1.8403 0.41614 f=3.128;pvalue
=0.029
Hospital expenses
in Kshs 0 - 999 19 1.5639 0.35785
1000- 1999 35 1.7020 0.34712
2000- 2999 30 1.9095 0.32160
>3000 21 1.8299 0.39479 f=4.360;pvalue
=0.006
ANOVA results of home care costs against management practices indicate that there is
no significant relationship between home care cost and management practices. This is
supported by an f statistic of 0.720 (p=0.542). There was also no significant relationship
between family support, source of funds and management practices. This was supported
by an f statistic of
40
2000- 2999 4 1.8929 0.22208
>3000 1 1.2857 f=0.720;p
value=0.542
Current
32 1.7969 0.38018
Source of funds income
Family
72 1.7510 0.36579
support
Savings 1 1.4286 f=0.579;
pvalue=0.562
Challenges
experienced Lack of funds 72 1.7232 0.37008
Am able 33 1.8463 0.35675 f=2.560;
pvalue=0.113
41
CHAPTER FIVE:
During the course of this study it was noted that diabetes education takes place weekly at
the mini clinic and it is self-sponsored. This is a barrier for those patients that do not
have the necessary funds. A shortage of nurses also hinders effective teaching of
diabetes self-management education to patients (Gross et al., 2010) and the diabetes
educators‟ cadre in Kenya is not officially recognized (MOPHS, 2010).These factors
may contribute to the study findings where majority of the patients having moderate
knowledge about diabetes self-management.
42
had high self-care behavior in a study in Myanmar (Sandhi et al., 2010) and
39.2% in a study in Ethiopia (Ayele et al., 2012).
The two most significant barriers to entry in the Kenyan health system are
the cost of care, and the availability of suitable care within a reasonable
distance (i.e., geographic barriers). According to NHSSP II, “the health
infrastructure in some regions of the country has coverage of one facility per
50-200 km,” making the availability of health resources to those who are
sick virtually non-existent in certain cases (NHSSP II, 2005).Most health
care providers are located in urban areas and therefore persons who live in
43
rural areas face significant challenges in receiving timely, safe and quality diabetes care.
They often forgo important diabetes management (Landon et al., 2004). Travelling the
long distances necessary to access diabetes clinics hinders patients from rural areas from
receiving quality diabetes care from the clinics (Mutea and Baker, 2008; Rourke, 2010).
In this study, 70.2% the respondents reported spending Ksh 100 – 199 ($1.20 – 2.40) for
a blood glucose test and 24% spent less than Ksh 99 ($1.19) for the same. This was
comparable to a study carried out in Mali, Mozambique and Zambia that found that
patients spend $2.38 per test (IIF 2004). Also 45.2% the respondents spent more than
Ksh 1000 ($12.04) monthly to manage their diabetes while another 34.6% spent Ksh500
– 999 ($ 6.00 – 12.04) monthly. A similar study in Sudan found that patients spent
$22.49 monthly on diabetes drugs (Hind, 2007).
Studies have shown that the cost of care nevertheless remains a paramount issue in
Kenya. For those who were ill but did not seek treatment, the high cost of care was noted
as the primary reason by 44% of those surveyed in KHHEUS 2003. Funding by the
national government to the health sector has been inadequate for minimizing out of
pocket expenses on care. As a result, funding for the health sector is financed primarily
by the private sector, with 36% of it originating from households mainly through out of
pocket spending (MOPHS, 2008).
The major source of funds was from family members (68.3%) while 30.8% relied on
their personal income. 69.23% of the respondents reported facing challenges in meeting
the costs required to manage their diabetes. Low socio-economic status including low
education levels has been associated with development of diabetes mellitus (Ismail et
al., 1999). An association between increasing poverty levels and increasing prevalence
of diabetes has been shown among women (Walker et al., 2011 and Robbins et al.,
2000). According to Lester, (2011). Ksh 510 ($6 U.S) enabled a patient to monitor her or
his glucose at home for a month and ksh 2125 ($25) subsidized eight months of insulin
44
therapy for a patient. But in a country where 60 percent of the population
lives on less than ksh 170 ($2) per day, these costs were often out of reach
Only 18.3% of the respondents needed to stay with relatives when they had
to visit the clinic as they lived too far away to travel back and forth from
their homes. The common means of transport used was public reported by
95.2% of the respondents. Almost half of the respondents (48.1%) are
accompanied by one person when they attend the clinic. 90.4% of the
respondents did not have a paid caretaker because they lived with family
members (26%) or were able to take care of themselves (74%). In this study
the utilization of herbal medicine was low as most of the respondents lived
in urban areas and their environs and were therefore more likely to make use
of conventional medicine. As seen 92.3% stated that they did not believe
herbalists or witchdoctors could cure their condition while 4.8% were not
sure. The frequency of utilization of alternative medicine is increasing
worldwide and is well documented in both African and global populations to
be between 20 to 80%. Cultural and economic reasons were largely
responsible for use of alternative medicine (Shappiro and Rapport 2009).
5.5 Conclusions
We can conclude from the study management of diabetes requires knowledge, motiva-
tion, training, and support, which is mostly provided by health care workers. Decisions
to seek care were influenced by a number of factors for example, severity of signs and
symptoms of the disease, recognition of signs and symptoms, support from the
community, availability of resources to seek care and services available at the health
care facilities.
The decision to seek care at healthcare facilities for many patients appeared to be
hindered by a lack of financial resources to pay the transport costs to health care
facilities, medical tests and prescribed medication. Travel distances from patients‟
residences, coupled with inadequate and poor public transport infrastructure were
reported to negatively influence the decisions to seek health care.
Recommendations
The hospital management should recast their communication strategy by revitalizing
their information, communication and education avenues in order to bolster information
on diabetic management.
The findings suggest that patients with type 2 diabetes require reinforcement of
knowledge through health communication to encourage them to understand their disease
management better, for more appropriate self-care.
46
The results of this study send a strong message to diabetes healthcare providers
and educators for the actual need for developing education and prevention
programs about diabetes targeting type 2 diabetes patients at outpatient clinics.
47
REFERENCES
Aalto A.M, Uutela A, Aro A.R .(1997). Health related quality of life among insulin-
dependent diabetics: disease-related and psychosocial correlates. Patient
Educational Counseling 30,215-225.
Adibe M and Aguwa C. (2009). Diabetes self-care knowledge among type 2 diabetic
outpatients in south-eastern Nigeria. International journal of drug development
and Research 1,85–104.
Almdal T., Scharling H., Jensen J.S., Vestergaard H. (2004).The independent effect of
type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a
population-based study of 13,000 men and women with 20 years of follow-up.
Archives of Internal Medicine, 164,1422–1426.
Alberti KG, Zimmet P.Z (1998). Definition, diagnosis and classification of diabetes
mellitus and its complications. Part 1: diagnosis and classification of diabetes
mellitus provisional report of a WHO consultation. Diabetes Medicine 15(7):
Amos A. F., McCarty D. J., Zimmet P. (1997). The Rising Global Burden of Diabetes
and Its Complications: Estimates and Projections to the Year 2010. Diabetic
Medicine.;14,S1–85
Amoah A. G., Owusu S. K., Adjei S. Diabetes in Ghana (2002). A Community Based
Prevalence Study in Greater Accra. Diabetes Research and Clinical Practice,
56,197–205
Araoye O.A. (2004). Research methodology with statistics for health and social
sciences. 2nd ed. Ibadan, Nathadex Publishers, 120
Aspray T. J., Mugusi F., Rashid S., Whiting D., Edwards R., Alberti K. G., Unwin N. C.
(2000), Rural and Urban Differences in Diabetes Prevalence in Tanzania: The
Role of Obesity, Physical Inactivity and Urban Living. Transactions of the Royal
Society of Tropical Medicine and Hygiene.;94,,637–44
Ayele K, Tesfa B, Abebe L, Tilahun T, Girma E. (2012). Self Care Behaviour among
Patients with Diabetes in Harari, Eastern Ethiopia: The Health Belief Model
Perspective. PLoS ONE 7(4).
48
Cooper R., Rotimi C., Kaufman J., Owoaje E., Fraser H., Forester T., Wilks R., Riste L.
K., Cruikshank J. K. (1997).Prevalence of NIDDM among Populations of the
African Diaspora. Diabetes Care.,20,343–48.
Connolly V., Unwin N., Sherriff P., (2001). Diabetes prevalence and socioeconomic
status: a population based study showing increased prevalence of type 2 diabetes
mellitus in deprived areas. Journal of Epidemiolgy and Community
Health ;54,173–7
Diabetes Leadership Forum (2010). Diabetes: The hidden pandemic and its impact on
Sub-Saharan Africa
Edwards R., Unwin N., Mugusi F., Whiting D., Rashid S., Kissima J., Aspray T. J.,
Alberti K. G. (2000).Hypertension Prevalence and Care in an Urban and Rural
Area of Tanzania. Journal of Hypertension 18(2),145–52
Ensor T, Cooper S. (2004) Overcoming barriers to health service access: influencing the
demand side, Health Policy and Planning, 19,69–79.
Eron LJ, Lipsky BA, Low DE, Nathwani D, Tice AD, Volturo GA.( 2003). Expert panel
on managing skin and soft tissue infections. Managing skin and soft tissue
infections, Expert panel recommendations on key decision points. Journal of
Antimicrobial Chemotherapy
Fisch A., Pichard E., Prazuck T., Leblanc H., Sidibe Y., Brucker G. (1987). Prevalence
and Risk Factors of Diabetes Mellitus in the Rural Region of Mali West Africa:
A Practical Approach. Diabetologia.;30,859–62.
Gu K., Cowie C.C., Harris M.I.(1998). Mortality in adults with and without diabetes in
a national cohort of the US population,1971–1993. Diabetes care, 21,1138–1145
Hu FB, Manson JE, Stampfer MJ, (2001).Diet, lifestyle, and the risk of type 2 diabetes
mellitus in women. New England Journal of Medicine;345,790–797
Hind E. E. (2007) Economic burden of diabetes on patients and their families in Sudan,
Karolinska Instituet, Thesis.
King H., Aubert R. E., Herman W. H. (1998). Global Burden of Diabetes. Prevalence,
Numerical Estimates and Projections. Diabetes Care. 21,1414–31
Laing S.P.,Swerdlow A.J., Slater S.D., Burden A.C., Morris A., Waugh N.R.,
Gatling W., Bingley P.J., Patterson C.C. (2003).Mortality from heart disease
in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia, 46,
760-765
Levitt N. S., Katzenellenbogen J. M., Bradshaw D., Hoffman M. N., Bonnici F. (1993). The
Prevalence and Identification of Risk Factors for NIDDM in Urban Africans in
Cape Town, South Africa. Diabetes Care.;16,601–7
50
Maina W. K., Ndegwa Z. M., Njenga E.W. and Muchemi E. W. (2011). Knowledge,
attitude, and practices related to diabetes among community members in four
provinces in Kenya: a cross-sectional study. Pan African Medical Journal
7(1), 1-10
Mbanya J. C., Pani L. N., Mbanya D. N., Sobngwi E., Ngogang J. (2000) Reduced
Insulin Secretion in Offspring of African Type 2 Diabetic Parents. Diabetes
Care.;23, 1761–65.
McLarty D. G., Swai A. B. M., Kitange H. M., Masuki G., Mtinangi B. L., Kilima
P. M., MaKene W. J., Chuwa L. M., Alberti K. G. (1989).Prevalence of
Diabetes and Impaired Glucose Tolerance in Rural Tanzania. Lancet.
8643):871–75
Merz CN, Buse JB, Tuncer D, Twillman GB (2002) Physician attitudes and
practices and patient awareness of the cardiovascular complications of
diabetes Journal of American College of Cardiology 40, 1877–81
Ministry of Public Health and Sanitation (2008). Annual Health Sector Statistics
Report, Division of Health Management Information Systems, Nairobi.
Ministry of Public Health and Sanitation (2010). Kenya National Diabetes Educators
Manual
Mutea, N.K., and Baker, C.M. (2008). Kenyan nurses‟ involvement in managing
hospitalized diabetic patients. International Journal of Nursing Practice, 14,
40-46.
51
Mwangi M.W, Githinji G.G., and Githinji F.W (2011). Knowledge and Awareness of
Diabetic Retinopathy amongst Diabetic Patients in Kenyatta National Hospital,
Kenya, International Journal of Humanities and Social Science Vol. 1, 140.
Naidoo N, Abdullah S, Bawah A, (2010). Ageing and adult health status in eight lower-
income countries: the INDEPTH WHO-SAGE collaboration. Global Health
Action.
Nwankwo C.H, Nandy B., Nwankwo Benjamin O. (2010). Factors influencing diabetes
management outcome among patients attending government health facilities in
South East, Nigeria, International Journal of Tropical Medicine 5(2) 28-36
Omar M. A. K., Seedat M. A., Motala A. A., Dyer R. B., Becker P. (1993).The
Prevalence of Diabetes Mellitus and Impaired Glucose Tolerance in a Group of
South African Blacks. South African Medical Journal., 83,641–43
Priyanka CK, Angadi MM. (2010). Hospital-based KAP study on Diabetes in Bijapur,
Karnataka. Indian Journal of Medical Specialties; 1,80-83.
Robbins JM, Vaccarino V, Zhang H, Kasl SV. (2000). Excess type 2 diabetes in
African-American women and men aged 40–74 and socioeconomic status:
evidence from the third national health and nutrition examination survey. Journal
of Epidemiological Community Health, 54(11), 839-845.
Rosenstock M, Strecher V, Becker M. (1998). Social learning theory and the health
belief model; Health Education Quarterly 15, 175–183.
Roglic G., Unwin N., Bennett P.H. (2005).The burden of mortality attributable to
diabetes: realistic estimates for the year 2000. Diabetes Care, 28, 2130–2135.
52
Nyunt, S. Howteerakul, N, suwannapong, N.& Ranjataun, (2010). Self-efficacy, self-
care behaviors and glycemic control among type-2 diabetes patients attending
two private clinics in Yangon, Myanmar. Southeast Asian Journal of Tropical
medicine and Public Health 41( 4), 943-951.
Shah VN., Kamdar PK., Shah N. (2009). Assessing the knowledge, attitudes and
practice of type 2 diabetes among patients of Saurashtra region, Gujarat.
International Journal Diabetes Developing Countries. 29, 118-22.
Snow RW, Schellenberg JRMA, Forster D, Mungala VO, Marsh K. (1994). Factors
influencing admission to hospital during terminal childhood illnesses in Kenya,
International Journal of Epidemiology.23,1013–1019.
Sobngwi E., Gautier J. F., Mbanya J. C (2003). Exercise and the Prevention of
Cardiovascular Events in Women. New England Journal of Medicine.348, 77–
79
Velkoff V and Kowal P (2007). Population Aging in Sub-Saharan Africa U.S. Census
Bureau, Current Population Reports, P95/07-1 Population Aging in Sub-Saharan
Africa: Demographic Dimensions.
Walker JJ, Livingstone SJ, Colhoun HM, Lindsay RS, McKnight JA, Morris AD, Petrie
JR. (2011). Effect of socioeconomic status on mortality among people with type
2 diabetes: a study from the Scottish diabetes research network epidemiology
group. Diabetes Care, 34(5), 1127-1132.
53
World Health Organization (2006). Definition of an older or elderly person. Retrieved
from http://www.who.int/healthinfo/survey/ageingdefnolder/en/index.html
World Health Organization (2007). A Framework for Action on Women, Ageing and
Health. Geneva:WHO
World Health Organization (2010). Gender, women and primary health care renewal.
Geneva:WHO
World Health Organization (2010). Message of the Regional Director on the occasion of
World Diabetes Day. Geneva:WHO
World Health Organization (2011). Non communicable disease country profiles, Kenya.
Zhang P, Zhang X, Brown J, (2010). Global healthcare expenditure on diabetes for 2010
and 2030. Diabetes Research and Clinical Practice 87,293–301
Zgibor, J.C. and Songer T.J.( 2001) External barriers to diabetes care: Addressing
personal and health systems issues. Diabetes spectrum, 14,23
APPENDICES
APPENDIX 1 CONSENT FORM
Purpose
54
The purpose of the research is to assess your level of awareness of diabetes
management, self management practices, socioeconomic and cultural factors
that affect your diabetes management.
Procedures
If you agree to be in this research, and sign this consent form, I or my
assistant will describe the questions you will be asked including their
purpose. The questions should take only 20 - 30 minutes of your time.
Confidentiality
The records of this study will be kept private. Anything you tell us will
remain confidential. In any sort of report of the study, we will not include
any information that will make it possible to identify you. We are not asking
for your name, address, or phone number. Your name and other identifying
information will not be kept with this survey. The surveys will be kept in a
locked file; only the researchers for this study will have access to the records.
55
have to give us a reason. Even if you sign the consent form, you are free to stop at any
time. You do not need to complete it if you feel uncomfortable doing it.
Contact
The researchers conducting this study are Esta Mwaloma and her assistant. You may
contact the researchers at anytime. Questions regarding the rights of research subjects
may be directed at the Ethical Committee at the Kenya Medical Research Institute.
In case of any queries or concerns, please contact the Principal investigator or KEMRI
on:
Esta Mwaloma
P.O. Box 55916-00200; Nairobi
Cell phone Number: +254 720 954 660
Email: [email protected]
OR
The Director;
Institute of Tropical Medicine and Infectious Diseases
Jomo Kenyatta University of Agriculture and Technology
P.O. Box 62200-00200; Nairobi
Tel: 067-52711
Email: [email protected]
OR
The Chairperson;
KEMRI National Ethical Review Committee
P.O. Box 54840-00200; Nairobi
Tel: 2722541-2713349-0722-205901
Consent
56
I have read the above information and understand that this survey is
voluntary and I may stop at any time. I consent to participate in the study.
_________________________________
Signature of participant Date
__________________________________
Signature of researcher/ research assistant Date
57
FOMU YA KIBALI
ANWANI:
Jina langu ni Esta Mwaloma. Mimi ni mwanafunzi kutoka chuo kikuuu la JKUAT.
Nakualika uwe mmoja wa wanawake ambao watuulizwa maswahili kuhusu ugonjywa
wa kisukari. Umechaguliwa kwa kuwa wewe ni mwanamke anayepokea matibabu ya
ugonjwa wa kisukari katika hospitali ya Kenyatta. Nakuoomba tafadhali usome fomu hii
kabla ya kukubali kujibu maswali. Kama huwezi kusoma naweza kukusomea ama
uniulize nikusomme ama mtu yeyote ambae ameeandikwa katika hospitali hii.
Mada
Utafiti huu unanuia kugundua kama wagonjwa wa Diabetis wanajua jinsi ya kuitawala,
jinsi wanvyo itawala na shida za fedha na kijamii ambazo zinawakumba.
` Utaratibu wa utafiti
Ukikubali kuhusika na utafuti huu na utie sahihi fomu hii, mimi ama msaidizi wangu
atakuekezea maswahili utakayoulizwa na umuhimu wao. Maswali yatachukua dakika
ishirini ama thelathini.
Manufaa na hatari
Utafiti huu ni kwa ajili ya masomo tu. Hakuna faida au manufaa kwa mhusika yeyote
kabla au baada ya utafiti. Hakuna madhara yoyote kwa wale wote watakaohusika katika
utafiti huu.
Usiri
Matokeo na maneno yote yatakayotokana na utafiti huu yatawekwa kwa usiri wa hali
ya juu. Hakuna jina la mhusika litatumiwa; ilhali nambari
58
maalumu tu ndizo zitakazotumika. Hoji zote zitawekwa ndani ya kabati na
kufungwa ndipo ziwe salama. Watafiti tu ndio wataweza kuona matokeo
haya.
Kutojihusisha
Kila mhusika, una uhuru wa kukataa kuhusishwa katika utafiti huu wala
hakuna hatari, machungu ama vitisho vyovyote vitakavyoambatana na
uamuzi wako. Hata ukikubali kuitkia kutia sahihi wakati wowote ule
unaweza kukatta kuendelea.
Mawasiliano
Watafiti ni Esta Mwaloma na msaidizi wake. Unaweza kuwasilian nao
wakati wowote. Ukiwa na maswali mengine kuhusu utafiti huu unaweza
kuwasiliana na KEMRI.
Esta Mwaloma
S.L.P: 55916-00200; Nairobi
Simu ya rununu: +254 720 954 660
Barua pepe: [email protected]
AU Msimamizi;
Institute of Tropical Medicine and Infectious Diseases
Jomo Kenyatta University of Agriculture and Technology
S.L.P: 62200-00200; Nairobi
Simu: 067-52711
Barua pepe: [email protected]
AU Mwenyekiti;
KEMRI National Ethical Review Committee
S.L.P: 54840-00200; Nairobi
59
Simu: 2722541-2713349-0722-205901
Kujitolea
Nimeesoma ama nimeelezwa fomu hii na naelewa ya kuwa sijalazimishwa
na wakati wowote naweza kusimamisha mahijiano haya. Nakubali kuwa
katika utafiti huu.
__________________________________
Sahihi ya mhusika Tarehe
________________________________
Sahihi ya mtafiti au msaidizi wake Tarehe
60
APPENDIX 2: QUESTIONNAIRE
Date of interview
Part 1: Background
1. How old are you/ When were you born?
Year of Birth
Age
1Primary
2Secondary
3College
4University
2 Other city
3 Town
4 Country side
61
5 Other
4 I am on formal employment
5 I am retired or a pensioner
2 Muslim
3 Traditional
4 Other (specify)
2 3 - 5 years
3 6 - 8 years
4 9 – 11 years
62
7. Which facility gave you this diagnosis?
1 Dispensary
2 Health Centre
3 Provincial Hospital
4 Referral Hospital
5 Private Hospital
7 Pharmacy
8 Other
8. When you were first diagnosed what advice or treatment were you given?
0 None
1 Insulin injections
2 Tablets
4 Lose weight
1Yes
2 I don‟t know
1Yes
2 I don‟t know
1Yes
2 4.4 - 6.1mmol/l
64
3 7.0 – 10.0 mmol/l
4 Other
13. Once blood glucose has been controlled should drugs be stopped?
0 No
1Yes
2 I don‟t know
1 Lowers it
2 Raises it
3 Has no effect
1 Lowers it
2 Raises it
3 Has no effect
65
16. What effect does any other sickness have on blood glucose?
0 Don‟t know
17. How often do you visit the KNH Diabetes mini clinic in a year?
1 Once a year
2 Twice a year
4 Every month
5 Every 3 months
6 Every 2 months
7 Other
18. Please tell me which conditions I have listed a doctor has EVER said you may
get from having Diabetes. 0 No 1 Yes
Diabetes complications Response
66
Heart Disease/Hypertension
Blindness
Kidney disease
1 Urine testing
2 Blood testing
4 Other
1Yes
2 Health Centre
3 Provincial Hospital
67
4 Referral Hospital
5 Private Hospital
7 Pharmacy
8 I test myself
9 Other
1 Once a day
2 Twice a day
3 Once a week
5 Every month
6 Other
68
23. What do you do to keep your diabetes under control?
0 Nothing
1 Inject insulin
3 Exercise
24. How often do you check your feet for sores or red spots?
0 I don‟t check
1 Once a week
2 Once a month
3 Everyday
4 Other
69
1 Once a week
2 Once a month
4 Other
1 Once a week
2 Once a month
3 Everyday
4 Other
27. If you suddenly feel shaky, nervous or hungry, what should you do?
0 Don‟t know
4 Other
70
28. How often do you get your eyes checked?
0 Don‟t know
2 Every year
5 Other
3 Other
2 In a gym
3 Other
71
31. If you don‟t, what prevents you from exercising?
1 I don‟t have time
5 I exercise
6 I fear exercising
8 Other
72
1 Refrigerator
3 Room temperature
4 Other
33. In the last 3 months, have you ever missed getting your prescribed insulin or
diabetic pills from the hospital?
0 No
1 Yes
1 Every month
35. When you miss your supplies of insulin or diabetic pills, what do you usually do?
1 Buy your own
73
3 Other
1Yes
2 Don‟t know
37. If you do not have a blood glucose meter how much do you usually pay for the
test?
1 0 - 99
2 100 - 199
3 > 200
38. If you use insulin/tablets to manage your diabetes, how much do you spend on it
monthly (plus syringes)?
1 0 - 499
2 500 - 999
3 > 1000
74
39. How far is the nearest health facility from your home?
1 < 1km
2 Between 1 and 5 km
3 > 5 km
40. Where do you stay when you come for treatment at KNH?
1 Home is in Nairobi/Environs
2 Relatives
3 Hotel
2 Public transport
3 Personal car
2 200 - 499
3 500 - 799
4 > 800
75
43 How many people accompany you when you are visiting KNH?
1 0
2 1
3 2
4 >2
43. How much do you spend per visit to KNH (excluding transport)?
1 0 - 999
2 1000 - 1999
3 2000 - 2999
4 > 3000
44. Have you or your family hired someone to take care of you
because of your ill health?
0 No
1 Yes
|_
45. IF YES, How much do you pay this person each month?
1 0 - 999
76
2 1000 - 1999
3 2000 - 2999
4 > 3000
46. Does someone from your family take care of you because of
your ill health without being paid for it?
0 No
1 Yes
47. During the past 12 months, how did you pay for or get the
medical services, care-givers, medicines, and medical supplies
that you, yourself, used?
1 By spending out of your current income/pension
5 By borrowing money
48. Please tell me which one of the following has prevented you
from getting medicines or medical care, over the last 12
months:
77
1 Lack of funds to pay for the care
2 Lack of transportation
7 I am able
8 Other
MASWALI
Nambari ya Fomu
Tarehe ya mahojiano
Part 1: Background
1. Una miaka mingapi/ Ulizaliwa mwaka gani?
Mwaka wa kuzaliwa
Miaka
78
1 Shule ya msingi
2 Shule ya upili
4 Chuo kikuu
2 Mji mwingine
3 Mji mdogo
4 Mashambani
2 Mimi ni mkulima
4 Nimeajiriwa
5 Nimestaafu
79
5. Dini yako ni gani?
1 Mkristo
2 Muislamu
3 Dini ya Kiasili
4 Nyingine (fafanua)
80
7. Hospitali gani ilikuambia kuwa una diabetis?
1 Zahanati
2 Hospitali ndogo
3 Hospitali ya mkoa
4 Hospitali kuu
5 Hospitali ya kibinafsi
6 Hospitali ya kidini
7 Duka la dawa
1 Kudungwa insulin
2 Tembe
4 Kupunguza kipimo
81
1Ndio
2 Sijui
1Ndio
2 Sijui
11. Je, kuwacha kuvuta sigara ama kunywa pombe kuna manufaa?
0 La
1Ndio
2 4.4 - 6.1mmol/l
4 Nyingine
82
1Ndio
2 Sijui
1 Inaongeza
2 Inapunguza
3 Haibadilishi
15. Je, mazoezi yanafanya nini kwa kiwango cha sukari yako?
0 Sijui
1 Inaongeza
2 Inapunguza
3 Haibadilishi
1 Inaongeza
2 Inapunguza
3 Haibadilishi
4 Saa zingine inapanda, saa zingine inashuka
17. Je, unamwona daktari wa klinkiki ndogo ya Daibetis ya KNH mara ngapi kwa
mwaka kwa uangalizi?
1 Mara moja kwa mwaka
83
2 Mara mbili kwa mwaka
4 Kila mwezi
7 Nyingine
18. Tafadhali niambie magonjwa yale daktari amekuelezea kuwa unawea pata
kuotkana na Diabetis. 0 La 1 Ndio
Magonjwa Ndio au LA
Upofu
Ugonjwa wa figo
1Ndio
21. Kama huna kifaa cha kupima glukos, unapimwa wapi kawaida?
1 Zahanati
2 Hospitali ndogo
3 Hospitali ya mkoa
4 Hospitali kuu
5 Hospitali ya kibinafsi
6 Hospitali ya kidini
7 Duka la dawa
8 Najipima
23. Je, wafanya nini ili sukari yako iwe katika kiwango kinachotakikana?
85
0 Hakuna
1 Natumia insulin
3 Mazoezi
1 kila wiki
2 kila mwezi
3 kila siku
4 Nyingine
1 Kila wiki
2 Kila mwezi
4 Nyingine
86
26. Je, wapia pressure mare ngapi?
0 Nikija kwa clinic
1 Kila wiki
2 Kila mwezi
3 Kila siku
4 Nyingine
27. Ukihisi njaa, kutetemeka ama kutoa jasho, unafaa kufanya nini?
0 Sijui
1 Kulala na kupumzika
4 Nyingine
2 Kila mwaka
87
5 Nyingine
3 Nyingine
2 Kwa gym
3 Nyingine
5 Nafanya mazoezi
88
mazoezi
8 Nyingine
33. Katika miezi 3 iliyopita, umewahi kukosa insulin/ tembe za diabetis yako
hospitalini?
0 Ndiyo
1 Hapana
2 Situmii insulin ama tembe
89
36. Je, waamini kuwa waganga ama madaktari wa mitshamba wanaweza kutibu
diabetis?
0 La
1Ndio
2Sijui
2 100 - 199
4 > 200
38. Kama watumia insulin watumia pesa nagpi kila mwezi kuinunua (pamoja na
sindano)?
1 0 - 499
2 500 - 999
3> 1000
2 Between 1 and 5 km
3> 5 km
2 Kwa familia
3 Kwa hoteli
2 Matatu au Basi
3 Gari langu
42. Watumia pesa ngapi kusafiri toka nyumbani na kurudi toka Kenyatta?
1 0 - 199
2 200 - 499
3 500 - 799
4> 800
21
32
4> 2
91
44. Watumia pesa ngapi ukija Kenyatta (toa nauli)?
1 0 - 999
2 1000 - 1999
3 2000 - 2999
4 > 3000
45. Je, wewe ama familia yako imeajiri mtu wa kukuangalia juu ya
ugonjwa wako?
0 La
1 Ndio
2 1000 - 1999
3 2000 - 2999
4 > 3000
1 Ndio
48. Kwa mwaka uliopita umetumia pesa toka wapi kulipia madawa
92
unayoutumia?
1 Pesa nazozoipata kwa mwezi/ pensheni
2 Wapaji wa madawa
3 Familia na marafiki
4 Akiba
5 Kuomba
6
uuza wanyama au shamba
8 Nyingine
93
APPENDIX 3: APPROVAL LETTERS
94
95
96
97
98
99
100
101